chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient received series from the Pfizer COVID-19 vaccine and received booster less than 90 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received series from the Pfizer COVID-19 vaccine and received booster less than 90 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 vaccine (Received monoclonal antibody treatment while he had COVID for 2 months.). Past adverse reactions to the above products included COVID-19 with Pfizer COVID-19 vaccine.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received series from the Pfizer COVID-19 vaccine and received booster less than 90 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received series from the Pfizer COVID-19 vaccine and received booster less than 90 days) had resolved.            Concomitant medications were not reported.  Patient received monoclonal antibody treatment while he had COVID. 2 months following treatment with monoclonal antibodies, he received the Moderna COVID-19 booster dose. He then found out that he was supposed to wait 3 months until he received the booster, and the booster may not work if he receives it in less time period. He was concerned if he received the booster before 90 days, it can interfere with the way the booster was supposed to work.  Treatment information was not reported.
Sore throat- swollen on the outside; Sore throat- swollen on the outside; Lymph nodes; This is a spontaneous report from a contactable pharmacist. A 49-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/expiry: unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took Taltz for psoriasis (pending clarification). It was reported that "day after HA etc" on an unspecified date; sore throat- swollen on the outside. "Lymph nodes?"  was also reported.  It was reported that the patient still sore (sore throat) and tested negative for COVID and strep throat. "Psoriasis TALTs med? - Second dose?" was also stated.  For their vaccine storage, it was reported that the state sent them. It had to be used within 5 days after removal - and stored under refrigeration, asking if it can be extended for at least a day would be helpful. The pharmacist was asking for extended stability of thawed vials in the refrigerator.    Information on the lot/batch number has been requested.
Patient developed a red rash with raised bumps (no pustules), covering a 9cm diameter area around the injection site.  The patient recieved supportive care.  Te allergy was added to her profile.
Chills all over body after second vaccine; Body aches after second vaccine; Temperature of 97.8 degrees Fahrenheit after second vaccine; 65-year-old patient, First dose in Jul2021, second dose on 11Nov2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65-year-old male patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), on 11Nov2021 as dose 2, single (Batch/Lot number: unknown, Expiration Date: Nov2022) at the age of 65 years for immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Prevnar 13 (first dose), administration date: Jul2021, when the patient was 65 years old, for immunization. The following information was reported: INCORRECT DOSE ADMINISTERED (non-serious) with onset 11Nov2021, outcome "unknown", described as "65-year-old patient, First dose in Jul2021, second dose on 11Nov2021"; PAIN (non-serious) with onset 12Nov2021, outcome "recovering", described as "Body aches after second vaccine"; CHILLS (non-serious) with onset 12Nov2021, outcome "unknown", described as "Chills all over body after second vaccine"; BODY TEMPERATURE DECREASED (non-serious) with onset 12Nov2021, outcome "unknown", described as "Temperature of 97.8 degrees Fahrenheit after second vaccine". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: no prior vaccinations within four weeks prior to the first administration date of the suspect vaccine. For event Temperature of 97.8 degrees Fahrenheit after second vaccine:  he has not repeated his temperature again.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Chills, nausea, vomiting, diarrhea, body aches.  Body aches for about 1 week Other symptoms 24 hours about 1 week after injection.
Per Mothers report: Patient was vaccinated, then watched his brother get vaccinated and said "whoa", then walked to the waiting area and was looking at items when he got pale and slumped against his brother down to the floor.   He apparently lost consciousness momentarily or certainly lost clarity.   Mother called for help and patient was placed on a cot.  Mother called for help.   I found the patient to be diaphoretic, cool, and bradycardic with a weak pulse by palpation at the wrist.  There was no rash, redness, nor airway tightness.  Indications were that this was a case of syncope.   There was no witness of a head injury and no scalp tenderness.  Legs were elevated and patient drank sips of water.  After 20 minutes, with parents collaboration, patient was moved outdoors to "fresh air" where he sat on a chair several minutes and then walked slowly then rapidly, finally achieving better color and a strong pulse.   Patient went home with both parents - on e driving and one observing.   Call back at 4:50 pm (approx 2.5 hrs after vaccination) the patient was snacking and drinking and improving slowly.
Just walked in the house from work. Sudden total numbness of left arm. Had hard time speaking, words were slow coming out and were slurred.  After about 10 minutes the numbness gave way to weakness. The speech was improving but slurred slightly for another 20 minutes.  Checked out by emt's and paramedics, then husband drove me to hospital.
2 days after vaccine his rt elbow became very sore/painful. Eventually lost use of fingers and his rt hand. Saw MD at two facilities (MRI's - "many tests"). Had physical therapy.  11/6/07 Reviewed hospital medical records which reveal patient experienced RUE pain, weakness & wasting of right hand.  Had been seen by routine chiropractor for manipulation of upper back which created pain 1 week prior to start of symptoms.  Seen by pain management 11/06, hand surgeon 2/26/07,  neurologist 3/19/07.  Received thoracic epidural injection which provided pain relief.  Exam by hand surgeon on 2/26/97 revealed obvious atrophy of right hand & distal forearm.  Referred to neurosurgery & PT/OT.  Returned to hand surgeon 3/19/07 s/p EMG/NCS w/diagnosis of Parsonage Turner syndrome.  Neurosurgeon did not feel C5-C6 herniation/stenosis was causing current problem.  Was to continue observation x 1 year & if no improvement, consider multiple tendon transfers surgery. FINAL DX: brachial plexus plexitis c/w Parsonage Turner syndrome. 1/15/2010 No change-worse
This case was reported by a pharmacist via call center representative and described the occurrence of injection site infection in a adult female patient who received SHINGRIX. In April 2018, the patient received the 1st dose of SHINGRIX. In April 2018, less than a week after receiving SHINGRIX, the patient experienced injection site infection, injection site erythema, injection site inflammation and vaccine administered at inappropriate site. The patient was treated with KEFLEX. On an unknown date, the outcome of the injection site infection, injection site erythema, injection site inflammation and vaccine administered at inappropriate site were unknown. The reporter considered the injection site infection, injection site erythema and the injection site inflammation to be probably related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX vaccine on an unknown arm. The healthcare professional reported that a dose of SHINGRIX was administered to the patient possibly slightly below the deltoid muscle, which led to vaccine administered to inappropriate site. Within 1 to 2 days, the injection site appeared red and inflamed. The patient saw her physician and was diagnosed with a skin infection and KEFLEX was prescribed. The healthcare professional was not at the pharmacy at time of report and was unable to provide any further information. The patient required emergency room visit.
Gillian Barre; Initial information was received on 18-Oct-2021 regarding an unsolicited valid Social Media serious case received from a consumer/non-healthcare professional.  This case involves an adult (unknown gender) patient who experienced Gillian Barre (Guillain-Barre syndrome) after patient received INFLUENZA VACCINE.  The patient's past medical treatments, vaccinations, concomitant medication and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious Gillian Barre (Guillain-Barre syndrome) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  The event outcome was unknown for the event.  The information on the batch number for this case has been requested.; Sender's Comments: This case concerns an adult (unknown gender) patient who experienced Guillain-Barre syndrome (unknown latency) after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. There is no further information regarding patient's medical condition at the time of vaccination and laboratory tests ruling out other alternate etiologies were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Patient reported feeling light headed within 2 minutes post flu vaccination. He said it was a common reaction.
Pt was seated in the 30 min waiting area. Pt states she felt her heart flutter and would like to be checked out. Pt was assisted in walking to the cot. Pt laid supine on the cot. Pt was placed on 4 lead EKG. Pt's EKG showed regularly irregular PVC's. Pt's vital are normal. Pt states she does not feel as if her heart is fluttering anymore. Pt's second 4-lead EKG is normal. Pt refused transport to hospital.
Shortness of breath or difficulty breathing, breakthrough COVID-19 case, hospitalization (8/18/2021--), admission to ICU
Extreme fatigue; This case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was unknown.   It was unknown if the reporter considered the fatigue to be related to Shingrix.     Additional Information: GSK Receipt Date: 14-JUL-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient received Shinrix and experienced extreme fatigue. Follow-up would not possible as no contact details were available. For tolerance of 2nd dose, refer case US2022AMR107007.; Sender's Comments:  US-GSK-US2022AMR107007:same report, other dose
This flu shot was received during an outreach event at a local school district for employees of the school district. Patient  voices prior to vaccination that this flu shot is her 1st flu shot. screening for negative for contraindications. Received flu vaccine.  The  school nurse called. The patient reports eating lunch then started to feel bad around 1pm.  She threw up,  dizzy, pale, sweat, flushed, BP  138/97.  Wearing mask, it made it worse, Temp 98.2.  Was encouraged to lay down for a while,  BP went down slightly to 132/92.  About 1.5 hour later, BP went down more and  felt better to go home.  Patient informed school nurse that she felt dizzy earlier in the week on Monday  while traveling on a windy road to and from a volleyball game. Patient was encouraged by school nurse to get a pregnancy test but patient denies possibility due to oral contraceptive use.
Horrible pain at injection site about 3-4 hours after injection. I could not move my arm without significant pain.  This intense pain lasted for at least  12 hours. At that point, I had no use of my right arm and pain was dull and achy.
I started seeing colors from my eyes as if I was light headed with no uphoria.  Now I have a slight head ache.
This spontaneous report as received from a registered nurse refers to a 55 year old female patient with herpes simplex virus genitals. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiration date, dose, route were not reported) because the patient believed that ZOSTAVAX would prevent outbreaks of Herpes Simplex Virus (HSV) genitals. No concomitant medications were reported. On an unknown dates, the patient had more outbreaks of HSV genitals since vaccination with ZOSTAVAX. The outcome of more outbreaks of HSV genitals was not reported. The relatedness between the event "more outbreaks of HSV genitals" and ZOSTAVAX was not reported. Additional information has been requested.
significant arm swelling, redness, and tenderness upper half of left arm initially, lasting for 4 days, then generalized joint aches, chills, fatigue, and myalgias for the next 11 days as of today
Started experiencing constipation and some noticeable pain on August 19th, 2022. She and I had recently traveled to State (Dec 2021) and then State (May 2022). We went to family's home for swim parties and cookouts every weekend during the summer of 2022. She had no signs of anything unusually wrong until 8/19/22. Within one week, she went to the doctor who sent her home to treat for constipation. The next day, she could not eat anything. I took her to Hospital where she was diagnosed with a restriction in her color and lesions on her pancreas and liver. They sent her by ambulance to Hospital. Dr. diagnosed her with a restricted colon and scheduled her for surgery. Multiple tests were run over the course of 3 weeks. She passed away within 4 weeks of symptoms and 3 weeks from diagnosis.
The shot was delivered five inches above my elbow, well below recommended location. I immediately felt a burning/electrical sensation run up my neck, into my jaw and through my left trapezoid. I thought it was a normal side effect and tried to ignore the pain for several days. I then sought relief through a massage therapist and began taking advil for pain. Three weeks later, the muscle in my back feels as if it is seizing up and I am in constant pain. It has relentless. My niece, a nurse, is the one who informed me the nurse who delivered the injection may have hit a nerve and that my symptoms are not directly related to the Pfizer vaccine. I am concerned others may have been injured in the same way by the same nurse. AND I have no idea when the nerve pain will subside or if it is permanent.
The next day after the vaccine (Tuesday), I started feeling tired and feverish. On Wednesday I had a headache and respiratory symptoms (stuffed nose/runny nose). I took a COVID test that day and the result was negative. Later that day I had a fever and started coughing with mucus and had swollen lymph node on my underarm. I took a COVID test again on Thursday (11/24) and it was also negative. I still had  a cough. On Saturday my symptoms improved. My husband started developing  a cough and respiratory symptoms on Saturday - we both had the fourth dose on the same day.  Before Saturday he only had muscle ache  and swollen lymph nodes. This morning (Sunday) we both took COVID tests and they turned out positive. Since the start of the COVID-19 pandemic we never tested positive (we tested a couple of times for work and travel).
"Moderna EUA Requirement"     Patient hospitalized for decreased responsiveness and vomiting x2days. Has had approximately a week or so of decline with increase seizures. Acute exacerbation of CHF
pt recv vax AUG97 & 23NOV97 pt devel a breakthrough case of chickenpox;
Pt vaccinated with Attenuvax developed dizziness, blurred vision, nausea & weakness. A probable dx of dehydration & viral synd. Also experienced muscle weakness and a petit mal seizure, feeling weak & shaky.
got Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got Covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jul-2021, the patient experienced COVID-19 (got Covid). At the time of the report, COVID-19 (got Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jul-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications details were provided.  No treatment Medications details were provided.
WEAKNESS, NUMBNESS IN ALL LIMBS, CHEST PAIN, NAUSEA, DIAPHORESIS, VASOVAGAL EPISODE Narrative: 35 yo male was seen at urgent care on 03/16/2021 after his covid19 vaccine. Pt stated he first developed chest pain, followed by dizziness, weakness. Felt like he was going to pass out, also had nausea, numbness in all limbs. Chest pain resolved after a few minutes. Pt has no hx of heart disease or diabetes. He had not eaten anything that morning. Denied previous issues with other vaccines. He had not been exposed to COVID19 (not that he knew of). Provider diagnosed patient with vasovagal episode. Patient was placed in supine position and given juice at the urgent care clinic. His blood pressure was 96/61 upon arrival and went up to 104/71. Baseline BP for patient is around 106-132/64-81. All symptoms resolved and pt was discharged home. PMH for patient includes: GERD, tinnitus, asthma
shingles; Information has been received from a lawyer and a patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On or about 14-JAN-2010, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a physician for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles was not recovered. The causality assessment was considered as related by the lawyer.
diarreah; Very sick; fever; chillks; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarreah), ILLNESS (Very sick), PYREXIA (fever) and CHILLS (chillks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarreah), ILLNESS (Very sick), PYREXIA (fever) and CHILLS (chillks). At the time of the report, DIARRHOEA (diarreah), ILLNESS (Very sick), PYREXIA (fever) and CHILLS (chillks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment were reported No Concomitant use was reporeted
Started with some dizziness, slight headache, following day very loose BM,  Then redness appeared about the size of a softball around at the injection sight and pretty hot to the touch, brusing at injection sight.   Redness and hot skin continuing for 3 days.  For vaccine lot #, mfg you'll need go contact the doctor, I do not have that information
3 DAYS AFTER INJECTION MOM NOTICE RED BASEBALL SIZE LUMP ON L ARM. MOM TOOK HIM TO ER. NO FEVER. THEN ON FEB27TH MOM NOTICE IN SAME AREA OF INJECTION SITE A MOSQUITO BITE SIZE AND ITCHY. Follow-up Information 22-MAR-2006: Mom reports to Health Dept that her son was seen in the ER on March 1 with reoccuring symptom as reported before but has Temp 102.5 and his L shoulder swelling up big. He was put on antibiotic for 7 days and Labs were done. His STABS were elevated. Mom said ER doc told her he was "infectious". He f/u with his doctor she said he was fine. Then on March 21 his arm started hurting and swelled to approx. 2cm - red hard bump and warm to touch, but fever. Encourage mom to follow-up with her doctor again.
heavy, tight feeling from the top of the arm to the last tip of the finger. swollen armpit. muscle pain on left upper back shoulder. heavy pain comes and goes, gets worse at night feels like arm is to heavy and might fall off. A vaccine shouldn't be forced ..